Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2017
18th World Conference on Lung Cancer
Access to all presentations that occur during the 18th World Conference on Lung Cancer in Yokohama, Japan
Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Download PDF of the Conference Program: Click Here.
Presentations will be available 24 hours after their live presentation time
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
-
+
P3.03 - Chemotherapy/Targeted Therapy
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
- Presentations: 33
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.03-001 - Immunotherapy Toxicity: Are General Practitioner Satisfied About Information Transmitted? A Retrospective Survey
09:30 - 09:30 | Author(s): L. Hamel Sénécal
- Abstract
Loading... -
+
P3.03-002 - Histone Deacetylase Inhibition Enhances the Antitumor Activity of a MEK Inhibitor in Lung Cancer Cells Harboring RAS Mutations
09:30 - 09:30 | Presenter: Tadaaki Yamada
- Abstract
Loading... -
+
P3.03-003 - ABCB1 3435C≫T Polymorphism Influences the Toxicity and Clinical Outcome of Patients with Taxane-Based Chemotherapy
09:30 - 09:30 | Presenter: Jia Zhong
- Abstract
Loading... -
+
P3.03-004 - The Frequency and Clinical Implication of ALK, ROS1, RET and NTRK1 Gene Rearrangements in Adenosquamous Lung Carcinoma Patients
09:30 - 09:30 | Presenter: Xiaohua Shi
- Abstract
Loading... -
+
P3.03-005 - Diagnosis and Treatment Analysis of Lung Enteric Adenocarcinoma: 6 Case Report and Review of the Literature
09:30 - 09:30 | Author(s): Chunwei Xu
- Abstract
Loading... -
+
P3.03-006 - Efficiency of Anlotinib as 3rd Line Treatment in Patients with Different EGFR Gene Status, an Exploratory Subgroup Analysis of ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han
- Abstract
Loading... -
+
P3.03-007 - LCMC2: Expanded Profiling of Lung Adenocarcinomas Identifies ROS1 and RET Rearrangements and TP53 Mutations as a Negative Prognostic Factor
09:30 - 09:30 | Presenter: Mark G Kris
- Abstract
Loading... -
+
P3.03-008 - Organoid Cultures of Lung Squamous Cell Carcinoma for Drug Screening
09:30 - 09:30 | Presenter: Ruoshi Shi
- Abstract
Loading... -
+
P3.03-009 - Concurrent Somatic Mutations in Driver Genes Were Significantly Correlated with Lymph Node Metastasis and Pathological Types in Solid Tumors
09:30 - 09:30 | Author(s): J. Yu
- Abstract
Loading... -
+
P3.03-010 - Identification of Mechanisms of Drug Resistance in RET-Rearranged Lung Cancer
09:30 - 09:30 | Presenter: Takashi Nakaoku
- Abstract
Loading... -
+
P3.03-011 - A Report of BRAF V600E Positive Lung Adenocarcinoma Patient Who Respond Well to Pemetrexed
09:30 - 09:30 | Presenter: Yoshiko Nakagawa
- Abstract
Loading... -
+
P3.03-012 - The Relationship between Efficacy of Wee1 Inhibitor AZD1775 and Mutational Status of TP53 in KRAS-Mutant Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Bo Mi Ku
- Abstract
Loading... -
+
P3.03-013 - Identification of Proteasomal Catalytic Subunit PSMA6 as a Therapeutic Target for Lung Cancer through a Pooled shRNA Screen
09:30 - 09:30 | Presenter: Mitsuo Sato
- Abstract
Loading... -
+
P3.03-014 - Tumor Cavitation in Patients with Primary Lung Cancer Following Apatinib Treatment
09:30 - 09:30 | Presenter: Man Jiang
- Abstract
Loading... -
+
P3.03-015 - ROS-1 Rearranged Non Small Cell Lung Cancer and Crizotinib: An Indian Experience
09:30 - 09:30 | Presenter: Vikas Talreja
- Abstract
Loading... -
+
P3.03-016 - Morphometric Genotyping Identifies Lung Cancer Cells Harboring Target Mutations; Cell-CT® Platform Detects Gene Abnormalities
09:30 - 09:30 | Presenter: Alan Nelson
- Abstract
Loading... -
+
P3.03-017 - Blood Samples NGS for Baseline Molecular Signature of Anotinib Treated Advanced NSCLC Patients in ALTER0303 Trial
09:30 - 09:30 | Presenter: Baohui Han
- Abstract
Loading... -
+
P3.03-018 - Tumor Cavitation in Lung Metastases in Patients with Solid Tumor Treated with Apatinib
09:30 - 09:30 | Presenter: Man Jiang
- Abstract
Loading... -
+
P3.03-019 - Activity of PARP Inhibitor in NSCLC with Germline and Somatic Mutation and in Silico Chemotherapy Lethality
09:30 - 09:30 | Presenter: Carmelia Maria Noia Barreto
- Abstract
Loading... -
+
P3.03-020 - Unique Molecular Profile of NSCLC in Thai Population
09:30 - 09:30 | Presenter: Narumol Trachu
- Abstract
Loading... -
+
P3.03-021 - In Vitro Pharmacogenomic Platform with a High-Purity Patient-Derived Cell Model
09:30 - 09:30 | Presenter: Hyun Chang
- Abstract
Loading... -
+
P3.03-022 - Lung Cancer in Young Patients: Higher Rate of Driver Mutations and Brain Involvement but Better Survival
09:30 - 09:30 | Author(s): A.M. Suidan
- Abstract
Loading... -
+
P3.03-023 - Nintedanib Selectively Inhibits the Activation and Tumor-Promoting Effects of Fibroblasts from Lung Adenocarcinoma Patients
09:30 - 09:30 | Author(s): M. Gabasa
- Abstract
Loading... -
+
P3.03-024 - Real-Life Experience and Clinical Characterization of BRAF V600E Mutation in Austrian NSCLC Patients
09:30 - 09:30 | Author(s): S. Schwab
- Abstract
Loading... -
+
P3.03-025 - Tumor Biomarkers for the Routine Care of Advanced Non-Small-Cell Lung Cancer: A Decade of Experience in Implementing Predictive Genomic Events
09:30 - 09:30 | Author(s): D. Rangachari
- Abstract
Loading... -
+
P3.03-026 - Cell-CT® Differential Detection of Dysplastic Bronchial Epithelial Cells from Patient Explants
09:30 - 09:30 | Presenter: Daniel J Sussman
- Abstract
Loading... -
+
P3.03-027 - LKB1 Loss Is Associated with Resistance to Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer Mouse Models
09:30 - 09:30 | Presenter: Irene Guijarro
- Abstract
Loading... -
+
P3.03-028 - WINTHER – a Study of Cancer Therapy Based on Tumor and Normal-Matched Biopsies – the Sheba Medical Center Lung Cancer Experience
09:30 - 09:30 | Author(s): T. Sella
- Abstract
Loading... -
+
P3.03-029 - ROS1 Alterations in Lung Adenocarcinoma: The Prognostic Role of Rearrangement and Copy Number Variation
09:30 - 09:30 | Author(s): Q. Guo
- Abstract
Loading... -
+
P3.03-030 - TP53 Alteration, a Potential Primary Cause of Early Progression in EGFR-Mutated NSCLC Patients Treated with First-Line TKIs
09:30 - 09:30 | Author(s): Y. Xu
- Abstract
Loading... -
+
P3.03-031 - Response to Crizotinib Can Occur in C-MET Overexpression NSCLC Independent of MET exon14 Alterations After First-Line EGFR-TKI Resistance
09:30 - 09:30 | Author(s): Y. Xu
- Abstract
Loading... -
+
P3.03-031a - The IGFBP-3 Methylation Status Could Define a New Alternative Schedule for NSCLC Treatment
09:30 - 09:30 | Presenter: Javier De Castro Carpeño
- Abstract
No abstract available for this presentation
-
+
P3.03-031b - Results of a Phase II Study of Stereotactic Radiosurgery Followed by Erlotinib for Patients with EGFR Mutation and Progression in 5 or Fewer Sites
09:30 - 09:30 | Presenter: Jared Weiss
- Abstract
Loading...
-
+
P3.04 - Clinical Design, Statistics and Clinical Trials
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
- Presentations: 15
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.04-001 - Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
09:30 - 09:30 | Presenter: Dawei Yang
- Abstract
Loading... -
+
P3.04-002 - A Randomized Phase II Study of Carboplatin plus Nab-Paclitaxel with or Without Nintedanib for NSCLC with IPF (J-SONIC): Trial in Progress
09:30 - 09:30 | Presenter: Kohei Otsubo
- Abstract
Loading... -
+
P3.04-003 - Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC
09:30 - 09:30 | Presenter: Helen J Ross
- Abstract
Loading... -
+
P3.04-004 - Treatment Rationale and Study Design for the TAKUMI Trial
09:30 - 09:30 | Presenter: Kentaro Tanaka
- Abstract
Loading... -
+
P3.04-005 - PD-L1 and Other Immuno-Markers Influenced by Osimertinib Treatment in Advanced Non-Small Cell Lung Cancer Patients (ATHENE Study)
09:30 - 09:30 | Author(s): Yongfeng Yu
- Abstract
Loading... -
+
P3.04-006 - SYSTEMS-2: Randomised Phase II Trial of Standard Versus Dose Escalated Radiotherapy for Pain in Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Miranda Jane Ashton
- Abstract
Loading... -
+
P3.04-007 - A Prospective Study of Apatinib in Advanced Small Cell Lung Cancer Patients Failed from Two or More Lines of Chemotherapy
09:30 - 09:30 | Presenter: Yutao Liu
- Abstract
Loading... -
+
P3.04-008 - A Phase 1b/2 Study of Atezolizumab With or Without Daratumumab in Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Rathi N Pillai
- Abstract
Loading... -
+
P3.04-009 - Stereotactic Body Radiotherapy to All Sites of Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Combined with Durvalumab and Tremelimumab
09:30 - 09:30 | Author(s): M. Bassetti
- Abstract
Loading... -
+
P3.04-010 - Validation of a ctDNA Methylation Assay to Differentiate Benign and Malignant Pulmonary Nodules: A Chinese Nationwide Multi-Center Study
09:30 - 09:30 | Presenter: Wenhua Liang
- Abstract
Loading... -
+
P3.04-011 - A Prospective Study to Optimize the Extent of Pulmonary Resection According to Decision-Making Algorithm in cStage IA NSCLC
09:30 - 09:30 | Presenter: Hong Kwan Kim
- Abstract
Loading... -
+
P3.04-012 - Phase 1 Study of the AXL Inhibitor DS-1205c in Combination with Osimertinib in Subjects with Metastatic or Unresectable EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Pasi A Jänne
- Abstract
Loading... -
+
P3.04-013 - Phase 1 Study of the Anti-HER3 Antibody Drug Conjugate U3-1402 in Metastatic or Unresectable EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Pasi A Jänne
- Abstract
Loading... -
+
P3.04-013a - CONFIRM: A Phase III Randomized Trial to Evaluate the Efficacy of Nivolumab versus Placebo in Relapsed Mesothelioma
09:30 - 09:30 | Presenter: Dean A Fennell
- Abstract
Loading... -
+
P3.04-013b - TTFields and Radiosurgery for 1-10 Brain Metastases from NSCLC: The Phase 3 METIS Study
09:30 - 09:30 | Author(s): Minesh P Mehta
- Abstract
Loading...
-
+
P3.05 - Early Stage NSCLC
- Type: Poster Session with Presenters Present
- Track: Early Stage NSCLC
- Presentations: 12
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.05-001 - Breath Analysis for Early Detection of Lung Cancer: The LuCID Study
09:30 - 09:30 | Presenter: Marc Phillipe Van Der Schee
- Abstract
Loading... -
+
P3.05-002 - The Effect of Nodule Size on the Sensitivity of the LuCED® Test for Lung Cancer
09:30 - 09:30 | Presenter: Michael Meyer
- Abstract
Loading... -
+
P3.05-003 - Serum Thioredoxin Reductase 1 as a Diagnostic Biomarker for Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Xiaozheng Kang
- Abstract
Loading... -
+
P3.05-004 - The Impact of EGFR Mutations on Incidence and Survival of NSCLC Patients with Brain Metastasis: a Single Center Retrospective Study
09:30 - 09:30 | Presenter: Wei-Yuan Chang
- Abstract
Loading... -
+
P3.05-005 - Hypermethylation of the RASSF1A and SOX1 Genes in Tumor DNA Predicts Unfavorable Overall Survival in Surgically Resected NSCLC Patients
09:30 - 09:30 | Presenter: Milica Kontic
- Abstract
Loading... -
+
P3.05-006 - Integrated Genomic Analysis to Assess the Molecular Signature of Japanese Patients with Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Mitsuhiro Isaka
- Abstract
Loading... -
+
P3.05-007 - Potential of CYFRA 21-1 and CEA to Predict Adjuvant Chemotherapy Benefit in Early-Stage Squamous Cell Lung Cancer
09:30 - 09:30 | Author(s): T. Muley
- Abstract
Loading... -
+
P3.05-008 - Potential of CYFRA 21-1 and HE4 to Detect Recurrence in Patients with Early-Stage Lung Adenocarcinoma
09:30 - 09:30 | Author(s): T. Muley
- Abstract
Loading... -
+
P3.05-009 - Hsa_circ_0044013: A Potential Novel Diagnostic Biomarker of Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Shuzhen Wei
- Abstract
Loading... -
+
P3.05-010 - NOTCH 1 and NOTCH 3 Expressions for Early Stage of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Eun Kyung Cho
- Abstract
Loading... -
+
P3.05-012 - Clinicopathological Determinants of Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Jong Ho Cho
- Abstract
Loading... -
+
P3.05-012a - Inference of Gene Expressions Associated with Recurrence of Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Seo Ree Kim
- Abstract
Loading...
-
+
P3.06 - Epidemiology/Primary Prevention/Tobacco Control and Cessation
- Type: Poster Session with Presenters Present
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
- Presentations: 10
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.06-001 - Tobacco Use, Awareness and Oral Health among Kanchipuram Silk Weavers, Tamil Nadu, India
09:30 - 09:30 | Presenter: Delfin Lovelina Francis
- Abstract
Loading... -
+
P3.06-002 - Tobacco Use, Awareness and Oral Health Status among Seafarers in Voc Port, Tuticorin, Tamilnadu, India
09:30 - 09:30 | Presenter: Delfin Lovelina Francis
- Abstract
Loading... -
+
P3.06-003 - What Do the Children Think about Smoking and How Are They Helped in Prevention?
09:30 - 09:30 | Author(s): D. Bafunno
- Abstract
Loading... -
+
P3.06-004 - Role Models “a Tool for Effective Tobacco Control Campaign”
09:30 - 09:30 | Presenter: Seye O Omiyefa
- Abstract
Loading... -
+
P3.06-005 - Informational Needs on Smoking Cessation of Cancer Patients
09:30 - 09:30 | Presenter: Meredith Elana Giuliani
- Abstract
Loading... -
+
P3.06-006 - The Government Willingness to Legislate Tobacco Control and Changes on Individual Behavior in Brazil
09:30 - 09:30 | Presenter: Ana Paula Leal Teixeira
- Abstract
Loading... -
+
P3.06-007 - Level of Awareness of Various Aspects of Lung Cancer Among College Students in India: Impact of Cancer Awareness Programes
09:30 - 09:30 | Presenter: Abhishek Shankar
- Abstract
Loading... -
+
P3.06-008 - Lung Cancer Pathways: A Five-Year Program to Reduce Impact Through Epidemiological Modelling and Investment in Prioritized Interventions
09:30 - 09:30 | Presenter: Nicole Marion Rankin
- Abstract
Loading... -
+
P3.06-009 - How Does Screening for the Early Detection of Lung Cancer Facilitate Smoking Cessation? A Qualitative Study of Screened Smokers
09:30 - 09:30 | Presenter: Ben Young
- Abstract
Loading... -
+
P3.06-009a - Lung Cancer in the Elderly - Histology, Localization and Gender Distribution in North Romania
09:30 - 09:30 | Author(s): T. Alexa-Stratulat
- Abstract
Loading...
-
+
P3.07 - Immunology and Immunotherapy
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
- Presentations: 17
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.07-001 - Overcoming Resistance to Anti-PD Immunotherapy in a Syngeneic Mouse Lung Cancer Model Using Adenovirus-Mediated Gene Therapy
09:30 - 09:30 | Presenter: Xiang Yan
- Abstract
Loading... -
+
P3.07-002 - Blocking of ADAM17 Mitigates Kras-Induced Lung Adenocarcinoma Possibly via Inhibition of IL-6 Trans-Signaling
09:30 - 09:30 | Presenter: Mohamed I. Saad
- Abstract
Loading... -
+
P3.07-003 - Analysis of Dendritic Cell Derived Exosomes That Suppressed Tumor Growth
09:30 - 09:30 | Presenter: Masakatsu Takanashi
- Abstract
Loading... -
+
P3.07-004 - GSDMD Is Required for Effector CD8+ T Cell Responses to Lung Cancer Cell
09:30 - 09:30 | Presenter: Tang Feng Lv
- Abstract
Loading... -
+
P3.07-005 - Activation of Toll-like Receptor-2 Promotes Proliferation in Human Lung Adenocarcinoma Cells
09:30 - 09:30 | Presenter: Patrick Kohtz
- Abstract
Loading... -
+
P3.07-006 - Pemetrexed Exerts Intratumor Immunomodulatory Effects and Enhances Efficacy of Immune Checkpoint Blockade in MC38 Syngeneic Mouse Tumor Model
09:30 - 09:30 | Presenter: Ruslan Novosiadly
- Abstract
Loading... -
+
P3.07-007 - Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis
09:30 - 09:30 | Author(s): D. Ajona
- Abstract
Loading... -
+
P3.07-008 - Development of Immunomonitoring Assays for Dendritic Cell-Based Lung Cancer Immunotherapy
09:30 - 09:30 | Presenter: Ond?ej Palata
- Abstract
Loading... -
+
P3.07-009 - PI3K/mTOR Pathway Altertions May Mediate PD-1/PD-L1 Blockade Resistance in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Tao Shou
- Abstract
Loading... -
+
P3.07-010 - T Helper 17 Cell Related Cytokines as a Prognostic Factor in Lung Cancer Patients
09:30 - 09:30 | Presenter: Bülent Karagöz
- Abstract
Loading... -
+
P3.07-011 - Investigation of Autologous Tumor-Killing Effect of Effusion-Associated Lymphocytes in Malignant Pleural Effusion of Lung Cancer
09:30 - 09:30 | Presenter: Yung-Hung Luo
- Abstract
Loading... -
+
P3.07-012 - Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases
09:30 - 09:30 | Presenter: Lucio Crinò
- Abstract
Loading... -
+
P3.07-013 - Cost-Effectiveness of Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Alexander Kuhlmann
- Abstract
Loading... -
+
P3.07-013a - PD-L1 Expression, Using SP142 and 22C3 Antibody Clones, in NSCLC Patients with Known Status of EGFR and ALK Genes
09:30 - 09:30 | Author(s): T. Kucharczyk
- Abstract
Loading... -
+
P3.07-013b - The Comparison Analysis of PD-1 Status Between 22C3 and 28-8 IHC Assay in Clinical Practice: A Single Institutional Experience
09:30 - 09:30 | Presenter: Yuki Nakamura
- Abstract
Loading... -
+
P3.07-013c - Computational Simulations for Investigating Electric Field Distributions When Delivering Tumor Treating Fields (TTFields) to the Lungs
09:30 - 09:30 | Author(s): H.S. Hershkovich
- Abstract
Loading... -
+
P3.07-013d - Tumor Treating Fields Induce Immunogenic Cell Death and Enhance Antitumor Effects of Anti-PD1 in NSCLC In-Vivo Models
09:30 - 09:30 | Author(s): T. Voloshin
- Abstract
Loading...
-
+
P3.08 - Locally Advanced Nsclc
- Type: Poster Session with Presenters Present
- Track: Locally Advanced NSCLC
- Presentations: 7
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.08-001 - Concurrent Chemoradiotherapy with Weekly Carboplatin-Paclitaxel May Be Feasible Option in inoperable Stage III NSCLC
09:30 - 09:30 | Author(s): Z. Calikusu
- Abstract
Loading... -
+
P3.08-002 - Lymphovascular Invasion Is Not a Postoperative Prognostic Factor for Large-Sized Lung Cancer
09:30 - 09:30 | Presenter: Atsushi Tajima
- Abstract
Loading... -
+
P3.08-003 - Multimodal Treatment in the Initially Inoperable Stage III N2 Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Eun Kyo Joung
- Abstract
Loading... -
+
P3.08-004 - Phase I/II Trial of Nab-Paclitaxel or Paclitaxel Plus Carboplatin with Concurrent Radiation for Inoperable Stage IIIA/B NSCLC
09:30 - 09:30 | Presenter: Aaron Laine
- Abstract
Loading... -
+
P3.08-005 - Hereditary Familial Overlap Syndrome with Multiple Synchronous Lung Tumors
09:30 - 09:30 | Presenter: Andrés F. Cardona
- Abstract
Loading... -
+
P3.08-006 - Treatment Response and Survival Outcomes Are Associated with Histologic Type in Non-Small Cell Lung Cancer Treated with Trimodal Treatment
09:30 - 09:30 | Presenter: Hong Kwan Kim
- Abstract
Loading... -
+
P3.08-006a - Predictive Value of Geriatric Assessment and Screening Tools in Elderly Patients with Stage III NSCLC for Concurrent Chemoradiation
09:30 - 09:30 | Author(s): Maite Antonio
- Abstract
Loading...
-
+
P3.09 - Mesothelioma
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
- Presentations: 12
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.09-001 - The Dosimetric Advantages of Intensity Modulated Proton Therapy (IMPT) for Mesothelioma after Pleurectomy/Decortication
09:30 - 09:30 | Presenter: Jean-Claude M Rwigema
- Abstract
Loading... -
+
P3.09-002 - Can We Do Better? Feasibility Dosimetric Study for Upfront Radical Radiotherapy in Mesothelioma
09:30 - 09:30 | Presenter: Timothy Mitchell
- Abstract
Loading... -
+
P3.09-003 - Heart Radiation Dose as a Risk Factor for Dyspnea Worsening After Multimodality Treatment for NSCLC and MPM: An Exploratory Analysis
09:30 - 09:30 | Presenter: Angela Botticella
- Abstract
Loading... -
+
P3.09-004 - Routine Clinical Parameters Can Stratify Survival Characteristics in Mesothelioma Patients Undergoing Surgery
09:30 - 09:30 | Presenter: Fraser Brims
- Abstract
Loading... -
+
P3.09-005 - The Results of Trimodality Treatment Strategy for Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Kazunori Okabe
- Abstract
Loading... -
+
P3.09-006 - Preoperative Six-Minute Walk Distance and Desaturation in Patients with Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Motoki Nagaya
- Abstract
Loading... -
+
P3.09-007 - Thoracic Asymmetry and Its Impact on Survival after Radiation and Surgery for Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: John Cho
- Abstract
Loading... -
+
P3.09-008 - Role of Surgery in the Multimodality Treatment of Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Bub-Se Na
- Abstract
Loading... -
+
P3.09-009 - Fourteen Cases Study of 5 Year Survivors of Malignant Pleural Mesothelioma Following Extrapleural Pneumonectomy
09:30 - 09:30 | Presenter: Ayumi Kuroda
- Abstract
Loading... -
+
P3.09-010 - 18 Years Single Center Experience of Surgical Resection of Malignant Pleural Mesothelioma After Induction Chemotherapy
09:30 - 09:30 | Author(s): O. Lauk
- Abstract
Loading... -
+
P3.09-010a - Late Response to Pembrolizumab in Advanced Biphasic Pleural Mesothelioma
09:30 - 09:30 | Presenter: Timothy Dudley Clay
- Abstract
Loading... -
+
P3.09-010b - Predicting Response to First Line Chemotherapy in Pleural Mesothelioma: A Random Forest Tree Model (Meso-CLICaP)
09:30 - 09:30 | Presenter: Oscar Arrieta
- Abstract
Loading...
-
+
P3.10 - Nursing/Palliative Care/Ethics
- Type: Poster Session with Presenters Present
- Track: Nursing/Palliative Care/Ethics
- Presentations: 7
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.10-001 - Prognostic Factors of Survival in Malignant Pleural Effusion
09:30 - 09:30 | Presenter: Fernando Conrado Abrão
- Abstract
Loading... -
+
P3.10-002 - Implementing an Innovative Distress/Supportive Care Screening Tool in a Lung Cancer Clinic
09:30 - 09:30 | Author(s): M. Pasquinelli
- Abstract
Loading... -
+
P3.10-003 - Assessing and Addressing Knowledge Gaps to Improve Lung Cancer Screening Rates
09:30 - 09:30 | Author(s): M. Pasquinelli
- Abstract
Loading... -
+
P3.10-004 - Immunotherapy: Emergency Department Provider Needs Assessment Survey
09:30 - 09:30 | Presenter: Lavinia Dobrea
- Abstract
Loading... -
+
P3.10-005 - National UK Thoracic Surgery PPI Group Identify Key Questions in Routine Clinical Care for Further Research
09:30 - 09:30 | Presenter: Amy Kerr
- Abstract
Loading... -
+
P3.10-006 - The Efficacy of Pistacia Terebinthus Soap in the Treatment of Erlotinib-Induced Skin Toxicity in Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Didem Tastekin
- Abstract
Loading... -
+
P3.10-007 - Sudden Death of the Patients with Lung Cancer
09:30 - 09:30 | Presenter: Yasushi Nakano
- Abstract
Loading...
-
+
P3.11 - Patient Advocacy
- Type: Poster Session with Presenters Present
- Track: Patient Advocacy
- Presentations: 3
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.11-001 - Factors Correlated With Time and Cost Diagnostic Lung Cancer
09:30 - 09:30 | Presenter: Inggar Pertiwi
- Abstract
Loading... -
+
P3.11-002 - Immunotherapies and Lung Cancer: Educating the Global Lung Cancer Community
09:30 - 09:30 | Presenter: Maureen Rigney
- Abstract
Loading... -
+
P3.11-003 - Addario Lung Cancer Foundation Patient Education Handbooks Fill a Health Literacy Void for Patients and Nurse Navigators
09:30 - 09:30 | Author(s): L. Fine
- Abstract
Loading...
-
+
P3.12 - Pulmonology/Endoscopy
- Type: Poster Session with Presenters Present
- Track: Pulmonology/Endoscopy
- Presentations: 6
- Coordinates: 10/18/2017, 09:30 - 16:00, Exhibit Hall (Hall B + C)
-
+
P3.12-001 - Lung Cancer in Patients with Interstitial Lung Disease: Clinical Characteristics and Impact on Survival
09:30 - 09:30 | Presenter: Shunsaku Hayai
- Abstract
Loading... -
+
P3.12-002 - Patients with Malignant Pleural Effusion who Succeeded Pleurodesis have a Longer Survival Rate - a 10-year Follow-up
09:30 - 09:30 | Presenter: Li-Han Hsu
- Abstract
Loading... -
+
P3.12-003 - Optimised Inhaler Therapy Is Superior to Supportive Care Alone for Dyspnoea in Patients with Coexisting COPD and Lung Cancer
09:30 - 09:30 | Presenter: David Peter Walder
- Abstract
Loading... -
+
P3.12-004 - Maidong on the Prevention and Treatment of Radiation Pneumonitis in Mice C57BL/6
09:30 - 09:30 | Presenter: Jiancheng Li
- Abstract
Loading... -
+
P3.12-004a - The Demonstration of the Possibility of the Mediastinal Mass Diagnosis by Means of the Cryo Biopsy
09:30 - 09:30 | Presenter: Jaroslaw Pierog
- Abstract
Loading... -
+
P3.12-004b - All Cause In-Hospital Mortality on Diagnostic Bronchoscopy in Lung Cancer Patients: Data from the Japanese DPC Database
09:30 - 09:30 | Presenter: Yoshihisa Hiraishi
- Abstract
Loading...